Work with me at the Central Institute of Mental Health (CIMH) in Mannheim and build with me the future of psychiatry.
The Westdeutscher Rundfunk (WDR) on October 8th and 9th, 2017, broadcasted an interesting feature on the “new paths of psychiatry”, which contains many statements I made during an interview on the future of psychopharmacology.
The interesting new antipsychotic compound cariprazine was recently approved by the European Medicines Agency (EMA). Its launch in Germany will be a new touchstone for the German Act on the Reform of the Market for Medicinal Products (AMNOG).
The new “Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017” were just published.